 33 PM / Updated 8 minutes ago BRIEF-Kalvista Pharmaceuticals Commences Two Clinical Trials Reuters Staff 
Jan 5 (Reuters) - Kalvista Pharmaceuticals Inc: * KALVISTA PHARMACEUTICALS COMMENCES TWO CLINICAL TRIALS 
* KALVISTA PHARMACEUTICALS INC - TOP-LINE RESULTS ARE EXPECTED IN SECOND HALF OF 2019 FOR KVD001 
* KALVISTA PHARMACEUTICALS INC - EXPECTS TO PROVIDE AN UPDATE ON STATUS AND PROGRESS OF HAE PORTFOLIO, INCLUDING KVD900, IN MID-2018 Source text for Eikon: Further company coverage: